CDC Health Alert Network (HAN) Health Advisory: Advice to Clinicians about Leptospirosis in U.S. Travelers Returning from Northern Israel

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

 

 


You are subscribed to the Health Alert Network (HAN) for Centers for Disease Control and Prevention (CDC). This information has recently been updated, and is now available.
 
HAN Logo

Advice to Clinicians about Leptospirosis in U.S. Travelers Returning from Northern Israel

The Israeli Ministry of Health is reporting an outbreak of leptospirosis in persons with exposure to natural water sources in the Golan Heights region of northern Israel after July 1, 2018. As of September 6, 2018, three persons with leptospirosis who traveled to Israel have been identified in the United States, with additional suspected cases reported and under investigation. Early symptoms of leptospirosis include fever, headache, chills, muscle aches, vomiting, diarrhea, cough, conjunctival suffusion (conjunctival redness without exudates), jaundice, and sometimes a rash. Clinicians should consider leptospirosis as a diagnosis in any patient who develops an acute febrile illness within 4 weeks of travel to one of the areas in northern Israel listed below since July 1, 2018.

Connect with emergency.cdc.gov: Follow emergency.cdc.gov on Facebook logo  Follow emergency.cdc.gov on Twitter logo   Follow emergency.cdc.gov on Linked In logo   Follow emergency.cdc.gov on RSS logo